The November 5 issue of JNCI features articles on new guidelines for testing cancer drugs in mice, the association between statin use and PSA level, X chromosome inactivation in breast and ovarian cancer, an evaluation of the Impact of Cancer Scale, characteristics and treatment patterns of patients with myelodysplastic syndromes, and the association of a genetic region with an increased risk of lung cancer.
